UNITED-FIRST-PARTNERS
United First Partners ("UFP"), a leading Special Situations Investment & Advisory Group is pleased to announce it has entered into a strategic alliance with the Mariana Group (“Mariana”), a leading Derivatives and Structured Products brokerage group, which is fully FCA regulated and based in London. The combination of UFP and Mariana creates a mid-sized financial services group with a strong reputation in the Equities and Derivatives space. Consequently, Mariana’s regulated entity has been renamed Mariana UFP LLP (FRN 551170) and oversee in excess of 70 professionals in London covering a broad spectrum of value added financial products and services.
This strategic alliance will add to UFP’s current offering in Equities in Europe, as Mariana is a primarily Derivatives and Structured Products brokerage operation, with a strong reputation amongst its peers. UFP and Mariana anticipate significant synergies across business lines in relation to the regulatory challenges expected in the years to come.
UFP and Mariana have upgraded their facilities and entered into new clearing arrangements in order to give Mariana UFP the tools to compete at the highest level.
In the US, UFP LLC (SEC regulated and member of FINRA and SIPC) will continue to operate as a standalone entity, although UFP and Mariana have plans to significantly expand the existing scope of activities in the region, in particular in the Derivatives segment.
Michael Hadjedj, Co-founder of UFP commented: “We are very excited by the strategic alliance we have formed with Mariana. We believe that our industry needs consolidation and Mariana UFP wants to be at the heart of it. UFP’s strong niche research offering combined with Mariana’s cross-asset execution platform and large market share in the derivatives space is a powerful combination to seize opportunities in our industry.”
Daniel Hawkins, Co-founder and CEO of Mariana added, “We are very pleased to join forces with UFP, which brings to Mariana access to a strong research franchise to complement our existing Macro-Economic and Derivative Strategy offering. We are now working towards generating synergies across the group’s business lines, and leveraging on UFP’s presence in the US. We are also preparing actively for the transition to MIFID II in Europe and feel our enlarged group is well positioned.”
About United First Partners
United First Partners (“UFP”) is a global leading Special Situations Investment & Advisory Group, offering a wide range of merchant banking and investment advisory services to institutional and private clients. These services range from sale and purchase of strategic assets to corporate finance, debt and equity capital markets and wealth management.
Our strategy and core values allowed us to build an extensive customer base including leading hedge funds, private equity funds, long-only funds, corporates, sovereign wealth funds and family offices. Our achievements, independence, unique business model and strong reputation have enabled UFP to become an attractive and reliable partner for business associates and talented professionals.
Over the past 6 years, UFP has been recognised as the #1 independent Pan European Special Situations research by industry leading survey Extel.
For further details, please visit www.utdfirst.com
About Mariana Capital
Mariana Capital Markets is a diversified, independent financial services intermediary providing bespoke advisory and strategy services. The firm was founded in 2009 to create and distribute innovative, high performance investment solutions and provide the highest quality service to our clients.
From our headquarters in the City of London, we offer global financial solutions ranging from Market Strategy and Tax Advisory to Structured Products and Estate Planning Solutions.
These services complement our status as a market leading execution venue for Cash Equities, Equity Futures and Options, Commodities, and Fixed Income products.
For further details, please visit www.marianainvestments.com
View source version on businesswire.com: http://www.businesswire.com/news/home/20170509006106/en/
Contact:
Press Enquiries:
Sara Caniggia
+44 207 050 6803
media@utdfirst.com
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Biocytogen and Acepodia Expand Collaboration Through Option-based Evaluation Framework for First-in-Class Bispecific and Dual-Payload ADCs (BsAD2C)9.1.2026 13:00:00 CET | Press release
Expanded collaboration builds on Acepodia and Biocytogen’s recent co-development efforts to evaluate selected bispecific antibody and dual-payload ADC programs Biocytogen Pharmaceuticals (Beijing) Co., Ltd. (Biocytogen, SSE: 688796; HKEX: 02315) and Acepodia (6976:TT), today announced that the companies have entered into an option and license agreement designed to enable the structured evaluation of bispecific antibody-drug conjugate (BsADC) programs to further advance the development of dual-payload bispecific antibody-drug conjugates (BsAD2Cs). The agreement grants Acepodia an option to obtain an exclusive worldwide license from Biocytogen for two BsADC programs. Under the terms of the agreement, Biocytogen is eligible to receive an upfront option fee and, upon Acepodia’s exercise of the option, additional payments including option exercise fees, development, regulatory, and commercial milestone payments, as well as royalties on future product sales. The financial terms of the agreem
Blockstream Capital Partners Announces Strategic Acquisition of Derivatives Trading Team from Numeus Group, Leveraging Strategic Partnership with Komainu9.1.2026 11:08:00 CET | Press release
Blockstream Capital Partners (“BCP”) today announced that it has entered into a strategic agreement to acquire a division within Numeus Group’s digital asset trading and investment business. The transaction includes the absorption of select Bitcoin focused trading strategies with a focus on yield generation as well as a ten person derivatives trading team led by Chief Investment Officer Deepak Gulati, a specialist in volatility and derivatives markets. Deepak Gulati, appointed Co-Chief Investment Officer of Blockstream Capital Management alongside Rodrigo Rodriguez, previously served as Global Head of Proprietary Trading at JPMorgan, before founding Argentiere Capital, a multibillion-dollar volatility-focused hedge fund. With a thesis that derivatives would drive Bitcoin and digital asset market maturity, he co-founded Numeus Group in 2021 to develop institutional-grade trading, risk management and market-structure capabilities. Komainu, an existing BCP strategic investment, has played
Autel Unveils Strategic Shift at CES 2026: Building the AI-Powered Infrastructure of Future Cities9.1.2026 10:44:00 CET | Press release
At the Consumer Electronics Show (CES), Autel Energy is presenting its latest AI-driven smart hardware and software systems for the future of intelligent urban operations. This year’s showcase highlights Autel’s shift from AI concept validation to scenario-based engineering deployment, emphasizing closed-loop execution across real-world infrastructure. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260101511436/en/ Autel Energy New Product Debut at CES 2026 Focusing on two key domains — Smart Energy and Smart Inspection — the company is unveiling a range of new products. In Smart Energy, Autel is introducing V2G (Vehicle-to-Grid) AC charger for homes and DC charging solution for fleets, strengthening its multi-tier energy touchpoint strategy from households to commercial operations. Live demonstrations at the booth will feature a smart charging robot showcasing automated plug-in capabilities. In Smart Inspection, Autel will
Allianz and Anthropic Forge Global Partnership to Advance Responsible AI in Insurance9.1.2026 10:00:00 CET | Press release
Anthropic’s safety-first AI meets Allianz's dedication to customer centricity, stakeholder trust, and regulatory excellenceThree focus areas of the partnership: workforce empowerment, operations automation through agentic AI, and regulatory compliance Allianz SE and Anthropic today announced a global partnership to accelerate the adoption of responsible Artificial Intelligence (AI) at Allianz. The collaboration centers on three transformative projects within Allianz Group designed to empower Allianz employees and accelerate operations, while setting new benchmarks for accuracy. “With this partnership, Allianz is taking a decisive step to address critical AI challenges in insurance. Anthropic’s focus on safety and transparency complements our strong dedication to customer excellence and stakeholder trust. Together, we are building solutions that prioritize what matters most to our customers while setting new standards for innovation and resilience,” said Oliver Bäte, CEO of Allianz SE.
MRM Health Secures FDA IND Clearance to Launch its Phase 2b Trial of MH002 in Mild-to-Moderate Ulcerative Colitis9.1.2026 07:00:00 CET | Press release
MH002 is currently the most advanced Live Biotherapeutic Product (LBP) based on a rationally-designed combination of disease specific bacteria (microbial consortia), for the treatment of inflammatory bowel diseases (IBD) STARFISH-UC Phase 2b trial is designed to confirm MH002’s early efficacy signals and favorable safety observed in Phase 2a studies MRM Health NV, a clinical-stage biopharmaceutical company pioneering microbiome-based therapeutics for inflammatory diseases and immune-oncology, today announced that the U.S. Food and Drug Administration (FDA) has granted clearance of its Investigational New Drug (IND) application for its lead program MH002. This enables the initiation of the STARFISH-UC Phase 2b clinical trial in patients with mild-to-moderate ulcerative colitis, marking a significant step forward in the development of next-generation therapies for inflammatory bowel diseases (IBD). About the STARFISH-UC Phase 2b Trial The STARFISH-UC trial is a randomized, double-blind,
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom
